CTRI/2015/04/005670已完成未知
AN OPEN-LABEL, RANDOMIZED, THREE-PERIOD, THREE-TREATMENT, THREE-SEQUENCE, CROSSOVER, BALANCED, SINGLE DOSE STUDYTO EVALUATE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS INJECTION OF REPOITIN INJECTION (TEST 1) 10000 IU/mL AND HUMAN SERUM ALBUMIN - FREE REPOITIN INJECTION (TEST 2) 10000 IU/mL OF SERUM INSTITUTE OF INDIA LTD COMPARED TO A LICENSED RECOMBINANT HUMAN ERYTHROPOIETIN INJECTION (REFERENCE) 10000 IU IN HEALTHY HUMAN ADULTS
Serum Institute of India Ltd0 个研究点目标入组 48 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Able to give written informed consent to participate in the study
- •2.Healthy adult males and/or females aged between 18-45 years (including both)
- •3.Subjects weight within normal range with minimum of 50 kg weight
- •4.Subjects with normal health as determined by personal medical history, clinical examination and laboratory examinations within the clinically acceptable normal range
排除标准
- •1.Subjects with any previous exposure to erythropoiesis stimulating agents.
- •2.History of allergy of biological products derived from mammalian albumin or any component of the study drug formulation
- •3.Any disease or condition which might compromise any body system.
研究者
相似试验
已完成
不适用
An randomly assigned, two-treatment, balanced, single dose study to evaluate the Pharmacokinetics and Pharmacodynamics of Intravenous Injection of REPOITIN and Human Serum Albumin - Free REPOITIN Injection of Serum Institute compared to licensed EPO injection injection in healthy adult subjectsCTRI/2015/11/006383Serum Institute of India Ltd66
Unknown
1 期
A study to evaluate effect of single oral dose of SDN-118 Capsules in healthy adult Human subjectsCTRI/2020/03/024009Sun Pharma Advanced Research Company Limited
进行中（未招募）
1 期
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Valacyclovir Oral Suspension compared to Valtrex® extemporaneous suspension in normal, healthy subjects under fasting conditions and to investigate the effect of food on the bioavailability of Valacyclovir Oral Suspension.ot applicable (submitted trial is a bioequivalence study in healthy subjects)MedDRA version: 20.0Level: HLGTClassification code: 10047438Term: Viral infectious disorders Class: 10021881CTIS2023-504760-42-00Dermax30
进行中（未招募）
不适用
Study to determine bioavailablity of 300 mg aliskiren mini-tablets vs 300 mg aliskiren market tablet.MedDRA version: 14.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2012-000855-15-Outside-EU/EEAovartis Pharma Services AG69
尚未招募
1 期
A clinical trial to evaluate and compare the blood levels of aliskiren mini-tablets with aliskiren market tablet under fasted condition and futher evaluate aliskiren mini-tablets under fed condition in healthy subjectsCTRI/2009/091/000723ovartis Healthcare Private Limited69